Let cost effectiveness models be open to scrutiny.
Poole
Chris
C
Agrawal
Samir
S
Currie
Craig J
CJ
D003362:Cost-Benefit Analysis; D013222:State Medicine / Q000191:economics*; D013673:Technology Assessment, Biomedical / Q000191:economics*; D006113:United Kingdom